Regeneron CSO Yancopoulos on Weight-Loss Drugs, Pipeline

Estimated read time 1 min read


Regeneron co-Chair, President and CSO George Yancopoulos discusses the company’s planned weight-loss drugs with Katie Greifeld at the JPMorgan Healthcare Conference in San Francisco. (Source: Bloomberg)

Source link

You May Also Like

More From Author

+ There are no comments

Add yours